Budiair | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Budiair
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Coral Budesonide

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Budiair

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

88 API Suppliers, 25 USDMF, 27 CEP/COS, 5 JDMF, 8 EU WC, 17 KDMF, 35 NDC API, 45 Listed Suppliers, $ API Reference Price

88 API Suppliers
25 USDMF
27 CEP/COS
5 JDMF
8 EU WC
17 KDMF
35 NDC API
45 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

240 Drugs in Development

240 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1369 FDF Dossiers, 54 FDA Orange Book, 1118 Europe, 23 Canada, 79 Australia, 39 South Africa, 56 Listed Dossiers

1369 FDF Dossiers
54 FDA Orange Book
1118 Europe
23 Canada
79 Australia
39 South Africa
56 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

TABLET, EXTENDED RELEASE;ORAL - 9MG
AEROSOL, FOAM;RECTAL - 2MG/ACTUATION
SPRAY, METERED;NASAL - 0.032MG/SPRAY
SUSPENSION;INHALATION - 0.25MG/2ML
SUSPENSION;INHALATION - 0.5MG/2ML
SUSPENSION;INHALATION - 1MG/2ML
CAPSULE, DELAYED RELEASE;ORAL - 6MG
CAPSULE, DELAYED RELEASE;ORAL - 9MG
CAPSULE, DELAYED RELEASE;ORAL - 3MG
AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 1 Gloria Interchem, 8 Ideal Cures, 2 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

62 Coating Systems & Additives, 49 Fillers, Diluents & Binders, 35 Controlled & Modified Release, 34 Thickeners and Stabilizers, 25 Solubilizers, 23 Direct Compression, 23 Granulation, 20 Taste Masking, 20 Parenteral, 20 Film Formers & Plasticizers, 19 Topical, 18 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 5 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 2 Coloring Agents

62 Coating Systems & Additives
49 Fillers, Diluents & Binders
35 Controlled & Modified Release
34 Thickeners and Stabilizers
25 Solubilizers
23 Direct Compression
23 Granulation
20 Taste Masking
20 Parenteral
20 Film Formers & Plasticizers
19 Topical
18 Lubricants & Glidants
11 Co-Processed Excipients
10 Emulsifying Agents
9 Empty Capsules
9 Disintegrants & Superdisintegrants
8 Chewable & Orodispersible Aids
5 Rheology Modifiers
5 Surfactant & Foaming Agents
5 API Stability Enhancers
4 Vegetarian Capsules
2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 147 News #PharmaBuzz

2 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
147 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 91 Regulatory FDF Prices, 51 Annual Reports

34 US Medicaid Prescriptions
91 Regulatory FDF Prices
51 Annual Reports

MARKET PLACE

20 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

20 APIs
17 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

39 US Patents, 4 US Exclusivities, 16 Health Canada Patents

39 US Patents
4 US Exclusivities
16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 21 USP, 15 Others

2 EDQM
21 USP
15 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,458 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 2CALLIDITAS

02 2TAKEDA PHARMS USA

filter Product Reset all filters

4 All

01 4BUDESONIDE

filter Exclusivity Expiration Date Reset all filters

4 All

01 12027-02-09

02 12028-12-15

03 12030-12-20

04 12031-02-09

filter Exclusivity Code Reset all filters

4 All

01 1NP

02 1ODE-389

03 1ODE-464

04 1ODE-466

Minakem Budesonide

Product Main Page

CALLIDITAS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-464

Exclusivity Expiration Date

2030-12-20

Application Number

215935

Product Number

1

Exclusivity Details

01

CALLIDITAS

BPI West

Not Confirmed

CALLIDITAS

Sweden

BPI West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-464

Exclusivity Expiration Date : 2030-12-20

Application Number : 215935

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CALLIDITAS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-389

Exclusivity Expiration Date

2028-12-15

Application Number

215935

Product Number

1

Exclusivity Details

02

CALLIDITAS

BPI West

Not Confirmed

CALLIDITAS

Sweden

BPI West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-389

Exclusivity Expiration Date : 2028-12-15

Application Number : 215935

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-466

Exclusivity Expiration Date

2031-02-09

Application Number

213976

Product Number

1

Exclusivity Details

03

TAKEDA PHARMS USA

BPI West

Not Confirmed

TAKEDA PHARMS USA

Japan

BPI West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-466

Exclusivity Expiration Date : 2031-02-09

Application Number : 213976

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2027-02-09

Application Number

213976

Product Number

1

Exclusivity Details

04

TAKEDA PHARMS USA

BioProcess International US West

Not Confirmed

TAKEDA PHARMS USA

Japan

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NP

Exclusivity Expiration Date : 2027-02-09

Application Number : 213976

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.